Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
Motley WW, Palaima P, Yum SW, Gonzalez MA, Tao F, Wanschitz JV, Strickland AV, Löscher WN, De Vriendt E, Koppi S, Medne L, Janecke AR, Jordanova A, Zuchner S, Scherer SS. Motley WW, et al. Among authors: koppi s. Brain. 2016 Jun;139(Pt 6):1649-56. doi: 10.1093/brain/aww055. Epub 2016 Mar 23. Brain. 2016. PMID: 27009151 Free PMC article.
Month-of-birth-effect in multiple sclerosis in Austria.
Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F. Walleczek NK, et al. Among authors: koppi s. Mult Scler. 2019 Dec;25(14):1870-1877. doi: 10.1177/1352458518810924. Epub 2018 Nov 22. Mult Scler. 2019. PMID: 30463473
Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.
Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W. Aboul-Enein F, et al. Among authors: koppi s. PLoS One. 2013 Nov 5;8(11):e79649. doi: 10.1371/journal.pone.0079649. eCollection 2013. PLoS One. 2013. PMID: 24223985 Free PMC article.
Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?
Kovacs GG, Peden A, Weis S, Höftberger R, Berghoff AS, Yull H, Ströbel T, Koppi S, Katzenschlager R, Langenscheidt D, Assar H, Zaruba E, Gröner A, Voigtländer T, Puska G, Hametner E, Grams A, Muigg A, Knoflach M, László L, Ironside JW, Head MW, Budka H. Kovacs GG, et al. Among authors: koppi s. Acta Neuropathol Commun. 2013 Nov 11;1:72. doi: 10.1186/2051-5960-1-72. Acta Neuropathol Commun. 2013. PMID: 24252716 Free PMC article.
Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc.
Bsteh G, Auer M, Iglseder S, Walchhofer LM, Langenscheidt D, Koppi S, Schauer-Maurer G, Stockhammer G, Berger T. Bsteh G, et al. Among authors: koppi s. Neurol Neuroimmunol Neuroinflamm. 2017 Feb 8;4(2):e323. doi: 10.1212/NXI.0000000000000323. eCollection 2017 Mar. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28210660 Free PMC article. No abstract available.
26 results